Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer Patients

NCT00718055 · Status: WITHDRAWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2009-02-10

No results posted yet for this study

Summary

The purpose of this study is to determine whether MRI with manganese containing contrast agent detects more livermetastasis compared to CT scan

Conditions

  • Neoplasm Metastasis
  • Liver
  • Colorectal Neoplasms
  • Magnetic Resonance Imaging
  • Contrast Media

Sponsors & Collaborators

  • Copenhagen University Hospital at Herlev

    lead OTHER

Principal Investigators

  • Vibeke Løgager, M.D. · Copenhagen University Hospital at Herlev

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00718055 on ClinicalTrials.gov